| Q92111242 | A Randomized Trial of Split Dose 3 L Polyethylene Glycol Lavage Solution, 2 L Polyethylene Glycol Lavage Combined With Castor Oil, and 1 L of Polyethylene Glycol Lavage Solution Combined With Castor Oil and Ascorbic Acid for Preparation for Colonosc |
| Q35939253 | A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia |
| Q42759567 | Acute hypotensive effects of oral cisapride and erythromycin in healthy subjects |
| Q35202119 | Anesthetic Routines: The Anesthesiologist's Role in GI Recovery and Postoperative Ileus |
| Q35048069 | Antipsychotics and QT prolongation |
| Q40444927 | Blockade of HERG cardiac K+ current by antifungal drug miconazole |
| Q36615966 | Can mosapride citrate reduce the volume of lavage solution for colonoscopy preparation? |
| Q33217289 | Cardiovascular parameters in anaesthetized guinea pigs: a safety pharmacology screening model |
| Q40061024 | Coexistence of hERG current block and disruption of protein trafficking in ketoconazole-induced long QT syndrome |
| Q26992006 | Current issues on safety of prokinetics in critically ill patients with feed intolerance |
| Q37507919 | Diabetic gastroparesis: diagnosis and management |
| Q35873847 | Diagnosis and therapy of irritable bowel syndrome. |
| Q35207439 | Diagnosis and treatment of chronic constipation--a European perspective |
| Q36579818 | Drug development for the irritable bowel syndrome: current challenges and future perspectives |
| Q28535919 | Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance system |
| Q36478089 | Drugs acting on serotonin receptors for the treatment of functional GI disorders |
| Q43904306 | Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia |
| Q51798941 | Effect of clebopride, antidopaminergic gastrointestinal prokinetics, on cardiac repolarization. |
| Q28364173 | Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial |
| Q34735891 | Efficacy and safety of gum chewing in adjunct to high-dose senna for bowel cleansing before colonoscopy: a single-blind randomized controlled trial |
| Q34385461 | Efficacy and tolerability of cisapride in children |
| Q35988493 | Efficacy of mosapride citrate with polyethylene glycol solution for colonoscopy preparation |
| Q35045973 | Electrophysiological effects of 5‐hydroxytryptamine on isolated human atrial myocytes, and the influence of chronic β‐adrenoceptor blockade |
| Q34611294 | Equine gastrointestinal motility--ileus and pharmacological modification |
| Q34579697 | Gastric emptying in diabetes: clinical significance and treatment. |
| Q55067343 | Gastrointestinal dysmotility in critically ill patients. |
| Q73626784 | Idiopathic and Diabetic Gastroparesis |
| Q34212885 | Irritable bowel syndrome: new agents targeting serotonin receptor subtypes |
| Q42702250 | Ketoconazole induces apoptosis in rat cardiomyocytes through reactive oxygen species-mediated parkin overexpression |
| Q34623569 | Levosulpiride in the management of functional dyspepsia and delayed gastric emptying |
| Q35624333 | Management of gastrointestinal involvement in scleroderma |
| Q35100294 | New developments in the treatment of functional dyspepsia |
| Q36285947 | New management approaches for gastroparesis |
| Q43349051 | Normal gastrointestinal transit after colonic resection using epidural analgesia, enforced oral nutrition and laxative |
| Q35219428 | Nutrition therapy for diabetic gastroparesis |
| Q35687012 | Nutritional intake in the critically ill: improving practice through research. |
| Q36903737 | Pathophysiology and management of diabetic gastropathy: a guide for endocrinologists. |
| Q37436502 | Pathophysiology and management of gastroparesis. |
| Q34285979 | Pharmacogenomics: will it change the field of medicine? |
| Q43541419 | Pharmacologic and clinical interest of serotonergic receptors of the gastrointestinal tract |
| Q38240886 | Pharmacological therapy of feed intolerance in the critically ills |
| Q35596862 | Pharmacology of serotonin: what a clinician should know. |
| Q35164691 | Pharmacotherapy for chronic gastro-oesophageal reflux disease and Barrett's oesophagus |
| Q35194467 | Pharmacotherapy of gastro-oesophageal reflux disease in children: focus on safety. |
| Q46217018 | Pilot postoperative ileus study of escin in cancer patients after colorectal surgery |
| Q83333177 | Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome |
| Q34089180 | Postoperative ileus: a preventable event |
| Q35016959 | Postoperative ileus: progress towards effective management |
| Q35669824 | Progress with novel pharmacological strategies for gastro-oesophageal reflux disease. |
| Q34548916 | Promotility medications--now and in the future |
| Q43350247 | Randomized controlled trial of bisacodyl suppository versus placebo for postoperative ileus after elective colectomy for colon cancer |
| Q35661061 | Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics |
| Q37132811 | Serotonin pharmacology in the gastrointestinal tract: a review |
| Q43692908 | Sinus arrest after the administration of intravenous metoclopramide |
| Q44091172 | Statistical analysis of QT interval as a function of changes in RR interval in the conscious dog. |
| Q28362551 | Stereoselective pharmacokinetics of cisapride in healthy volunteers and the effect of repeated administration of grapefruit juice |
| Q34504541 | Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). |
| Q24242508 | Systemic prokinetic pharmacologic treatment for postoperative adynamic ileus following abdominal surgery in adults |
| Q44505189 | The effect of metoclopramide on QT dynamicity: double-blind, placebo-controlled, cross-over study in healthy male volunteers |
| Q42780042 | Treatment functional GI disease: the complex pharmacology of serotonergic drugs |
| Q37354119 | Treatment of nausea and vomiting in terminally ill cancer patients. |